Precision medicine is a type of medical therapy and prevention that considers individual differences in genes, environment, and lifestyle, and allows for tailoring based on factors that may influence treatment response. Several genetic and epigenetic risk factors have been linked to late-onset Alzheimer's disease susceptibility (AD). As a result, including genetic risk variables into the AD prevention approach, which has previously mostly focused on universal risk-reduction methods for the whole population rather than personalized, targeted therapies, may be advantageous. This approach to medicine holds a lot of promise for treating the intricacies of people with diverse genetics, lifestyle circumstances, and medical comorbidities who may have different responses to treatment.
- Precision Medicine
- Biomarkers for Alzheimer's Disease
- “One-Size-Fits-All” Approach to AD Prevention
- Future Perspectives
Jacqueline Tuppen
Cogs Club, United Kingdom
Jun Hua
Johns Hopkins University School of Medicine, United States
Mario Allegra
University of Palermo, Italy
Suren A Tatulian
University of Central Florida, United States
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United StatesSubmit your abstract Today
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States